Prolonged Infusion of Somatostatin with Glucagon Replacement Increases Plasma Glucose and Glucose Turnover in Man*
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
To determine the effect of isolated beta-cell impairment on glucose turnover, we administered a 46-h infusion of somatostatin (200 micrograms/h) with glucagon replacement (0.75 ng/kg X min) to eight normal men. Fasting plasma insulin levels fell slightly, but significantly, from 8 +/- 2 (+/- SEM; control) to 6 +/- 2 microU/ml 46 h after beginning the infusion (P less than 0.001). Over the same period, fasting plasma glucose rose from 89 +/- 2 to 114 +/- 2 mg/dl (P less than 0.001), and plasma glucagon levels remained unchanged (79 +/- 5 vs. 82 +/- 8 pg/ml P = NS). Glucose turnover was measured by isotope dilution using [3-3H]glucose. The glucose production rate rose consistently from a baseline value of 2.08 +/- 0.04 to 2.45 +/- 0.06 mg/kg X min (P less than 0.01). The glucose disposal rate also rose consistently from 2.11 +/- 0.04 to 2.53 +/- 0.09 mg/kg X min (P less than 0.01). We conclude that prolonged mild selective insulin deficiency produced by infusion of somatostatin with glucagon replacement in normal men causes an elevation of the fasting plasma glucose level, which is maintained by glucose overproduction rather than by glucose underutilization. Overproduction of glucose may also be important in maintaining basal hyperglycemia in patients with noninsulin-dependent diabetes mellitus who have a similar impairment of insulin secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
Defronzo, R., Deibert, D., Hendler, R., Felig, P., & Soman, V. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109394 · Cited by 188
RetractedAbnormal Alpha-Cell Function in Diabetes: Response to Carbohydrate and Protein Ingestion
Müller, W. A., Faloona, G. R., Aguilar-Parada, E., & Unger, R. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007162830301 · Cited by 626
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man
Felig, P., & Wahren, J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106659 · Cited by 269
Cherrington, A. D., Chiasson, J. L., Liljenquist, J. E., Jennings, A. S., Keller, U., & Lacy, W. W. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108596 · Cited by 249
Saccà, L., Sherwin, R., Hendler, R., & Felig, P. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109384 · Cited by 162
Concentrations of Glucagon and the Insulin: Glucagon Ratio in the Portal and Peripheral Circulation
Felig, P., Gusberg, R., Hendler, R., Gump, F. E., & Kinney, J. M. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38286 · Cited by 91
Maintenance of Basal Plasma Glucose and Insulin Concentrations in Maturity-Onset Diabetes
Holman, R. R., & Turner, R. C. (1979) · Diabetes · doi:10.2337/diab.28.3.227 · Cited by 62
Cited by
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
The role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238
“In healthy subjects made modestly insulin deficient with somatostatin, administration of glucagon in amounts estimated to replace fasting levels cause hyperglycaemia [6,19,41].”
BackgroundKelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110
“Dysregulated glucagon secretion [1–7] and inappropriately elevated hepatic glucose production contribute to hyperglycaemia in patients with type 2 diabetes [4,6,8,9].”
BackgroundMetabolic effects of glucagon in humans
Adeva-Andany, M. M., Funcasta-Calderón, R., Fernández-Fernández, C., Castro-Quintela, E., & Carneiro-Freire, N. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.12.005 · Cited by 94
Kazierad, D. J., Bergman, A., Tan, B., Erion, D. M., Somayaji, V., Lee, D. S., & Rolph, T. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12672 · Cited by 44
Metadata
- Authors
- WARD, W. K., BEST, J. D., HALTER, J. B., & PORTE, D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1984-03
- Volume
- 58
- Issue
- 3
- Pages
- 449-453
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2029859167
- Cited by
- 18
- References
- 7
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prolonged Infusion of Somatostatin with Glucagon Replacement Increases Plasma Glucose and Glucose Turnover in Man*. https://app.cochat.ai/papers/10.1210/jcem-58-3-449
- The paper
- WARD, W. K., BEST, J. D., HALTER, J. B., & PORTE, D. (1984). Prolonged Infusion of Somatostatin with Glucagon Replacement Increases Plasma Glucose and Glucose Turnover in Man*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-58-3-449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.